目的观察社区服药无缝连接管理模式对精神分裂症患者社会功能和生活质量的影响,为提高精神分裂症患者社区管理质量提供参考。方法将符合入组标准50对精神分裂症患者分为研究组与对照组,研究组实施服药无缝连接管理,对照组实施常规社区...目的观察社区服药无缝连接管理模式对精神分裂症患者社会功能和生活质量的影响,为提高精神分裂症患者社区管理质量提供参考。方法将符合入组标准50对精神分裂症患者分为研究组与对照组,研究组实施服药无缝连接管理,对照组实施常规社区管理。分别在基线、干预后6个月和干预后1年行患者社会功能缺陷(SDSS)及生活质量(QOL-BRIEF)评估。结果基线时研究组和对照组SDSS评分无统计学意义(7.1±2.9vs 6.9±2.3);干预后6个月实验组SDSS评分显著低于对照组(5.1±2.4 vs 6.3±2.3,t=2.66,P=0.009);干预后1年实验组SDSS评分仍然显著低于对照组(4.4±2.0 vs 6.0±2.4,t=3.50、P=0.001);干预后1年研究组WHOQOLBRIEF量表在躯体功能维度(13.8±1.6)、心理功能维度(15.0±2.4)、社会关系维度(15.1±2.4)及环境维度(14.9±2.1)评分显著高于对照组(11.7±1.3、12.6±1.2、12.5±2.1、12.16±1.55,P<0.001)。结论社区服药无缝连接管理模式对精神分裂症患者的社会功能和生活质量改善显著优于常规社区管理。展开更多
目的观察社区服药无缝连接管理模式对精神分裂症患者的疗效,为优化精神分裂症社区管理与治疗模式提供参考。方法选择社区管理的精神分裂症患者100名,分为社区服药无缝连接管理组和常规社区管理组(每组各50例)。分别在基线、干预后6个月...目的观察社区服药无缝连接管理模式对精神分裂症患者的疗效,为优化精神分裂症社区管理与治疗模式提供参考。方法选择社区管理的精神分裂症患者100名,分为社区服药无缝连接管理组和常规社区管理组(每组各50例)。分别在基线、干预后6个月和干预后12个月行阳性和阴性症状量表(PANSS)、社会功能缺陷筛选量表(SDSS)、自知力与治疗态度问卷测评,重复测量方差分析比较不同时间段两组各量表评分差异。结果两组基线时各量表评分无显著差异。干预组在第6个月PANSS总分、阳性量表总分和阴性量表总分均显著低于对照组(49.30±11.67 vs 61.12±17.48,9.24±3.44 vs 12.72±5.95,14.02±3.78 vs 16.58±6.98);干预组在第12个月PANSS总分、阳性量表总分和阴性量表总分均显著低于对照组(44.68±8.47 vs 57.86±16.08,8.12±2.24 vs 11.26±5.36,12.86±3.25 vs16.24±6.88);重复测量方差分析结果显示:控制了时间效应后,干预措施对PANSS、阳性量表、阴性量表和SDSS量表评分具有显著影响(P<0.05);两组干预后ITAQ量表评分、复发率差异无统计学差异,服药依从性干预组高于对照组(P=0.006)。结论在社区康园工疗站网络完善的地区,实施社区服药无缝连接管理模式对精神分裂症患者的疗效显著优于常规管理。展开更多
The purpose of this paper is to implement a pharmaceutical care program in psychiatric outpatients in a community pharmacy. Outpatients （536） with psychiatric treatment requiring the dispensing of medication prescri...The purpose of this paper is to implement a pharmaceutical care program in psychiatric outpatients in a community pharmacy. Outpatients （536） with psychiatric treatment requiring the dispensing of medication prescribed by a psychiatrist were followed up in a community pharmacy, where different medicines were prescribed as PS （pharmaceutical specialties）, PC （pharmaceutical compounding） or both PS and PC. Each prescription was registered with details on a patient level. Also, three reporting sheets were designed： patients profile, patients monitoring and patients counseling. The total study population in the community pharmacy consisted of 536 outpatients： 357 （66.6%） females and 179 （33.4%） males. Most of the outpatients （78.5%） have health insurance, 50% correspond to public and 28.5% to private institution. The other patients （21.5%） do not have medical insurance. We also observed that the education level of these patients was： primary school 19.1%; high school 45.9%; college 15.3% and university 20.7%. Many patients had more than one psychiatric diagnosis, to whom were prescribed different medicines. All the medication studies on the charts were screened for prescriptions with antidepressants and other psychotropic drugs, starting on the date of first diagnosis made by a psychiatrist. The counseling to the patients was also registered. The possibility of the follow-up of these outpatients in the community pharmacy promoted the development of the psychiatric pharmacy and all advances in care for patients with mental health needs, working in closer collaboration with psychiatrists.展开更多
文摘目的观察社区服药无缝连接管理模式对精神分裂症患者社会功能和生活质量的影响,为提高精神分裂症患者社区管理质量提供参考。方法将符合入组标准50对精神分裂症患者分为研究组与对照组,研究组实施服药无缝连接管理,对照组实施常规社区管理。分别在基线、干预后6个月和干预后1年行患者社会功能缺陷(SDSS)及生活质量(QOL-BRIEF)评估。结果基线时研究组和对照组SDSS评分无统计学意义(7.1±2.9vs 6.9±2.3);干预后6个月实验组SDSS评分显著低于对照组(5.1±2.4 vs 6.3±2.3,t=2.66,P=0.009);干预后1年实验组SDSS评分仍然显著低于对照组(4.4±2.0 vs 6.0±2.4,t=3.50、P=0.001);干预后1年研究组WHOQOLBRIEF量表在躯体功能维度(13.8±1.6)、心理功能维度(15.0±2.4)、社会关系维度(15.1±2.4)及环境维度(14.9±2.1)评分显著高于对照组(11.7±1.3、12.6±1.2、12.5±2.1、12.16±1.55,P<0.001)。结论社区服药无缝连接管理模式对精神分裂症患者的社会功能和生活质量改善显著优于常规社区管理。
文摘目的观察社区服药无缝连接管理模式对精神分裂症患者的疗效,为优化精神分裂症社区管理与治疗模式提供参考。方法选择社区管理的精神分裂症患者100名,分为社区服药无缝连接管理组和常规社区管理组(每组各50例)。分别在基线、干预后6个月和干预后12个月行阳性和阴性症状量表(PANSS)、社会功能缺陷筛选量表(SDSS)、自知力与治疗态度问卷测评,重复测量方差分析比较不同时间段两组各量表评分差异。结果两组基线时各量表评分无显著差异。干预组在第6个月PANSS总分、阳性量表总分和阴性量表总分均显著低于对照组(49.30±11.67 vs 61.12±17.48,9.24±3.44 vs 12.72±5.95,14.02±3.78 vs 16.58±6.98);干预组在第12个月PANSS总分、阳性量表总分和阴性量表总分均显著低于对照组(44.68±8.47 vs 57.86±16.08,8.12±2.24 vs 11.26±5.36,12.86±3.25 vs16.24±6.88);重复测量方差分析结果显示:控制了时间效应后,干预措施对PANSS、阳性量表、阴性量表和SDSS量表评分具有显著影响(P<0.05);两组干预后ITAQ量表评分、复发率差异无统计学差异,服药依从性干预组高于对照组(P=0.006)。结论在社区康园工疗站网络完善的地区,实施社区服药无缝连接管理模式对精神分裂症患者的疗效显著优于常规管理。
文摘The purpose of this paper is to implement a pharmaceutical care program in psychiatric outpatients in a community pharmacy. Outpatients （536） with psychiatric treatment requiring the dispensing of medication prescribed by a psychiatrist were followed up in a community pharmacy, where different medicines were prescribed as PS （pharmaceutical specialties）, PC （pharmaceutical compounding） or both PS and PC. Each prescription was registered with details on a patient level. Also, three reporting sheets were designed： patients profile, patients monitoring and patients counseling. The total study population in the community pharmacy consisted of 536 outpatients： 357 （66.6%） females and 179 （33.4%） males. Most of the outpatients （78.5%） have health insurance, 50% correspond to public and 28.5% to private institution. The other patients （21.5%） do not have medical insurance. We also observed that the education level of these patients was： primary school 19.1%; high school 45.9%; college 15.3% and university 20.7%. Many patients had more than one psychiatric diagnosis, to whom were prescribed different medicines. All the medication studies on the charts were screened for prescriptions with antidepressants and other psychotropic drugs, starting on the date of first diagnosis made by a psychiatrist. The counseling to the patients was also registered. The possibility of the follow-up of these outpatients in the community pharmacy promoted the development of the psychiatric pharmacy and all advances in care for patients with mental health needs, working in closer collaboration with psychiatrists.
